Aspire Biopharma Holdings, Inc.

Nasdaq:ASBPNasdaq:ASBPW

Pharmaceutical Preparations·ESTERO, FL

Summary Financials

Revenue

—

Adj. EBITDA

—

Net Income

$4.5M

FY 2024

EPS (Diluted)

—

Stock Price

$1.16

-11.5%

2026-03-06

52W Range

$1.14 – $35.20

P/E Ratio

—

Market Cap

$124.7M

Cash

$497,259

FY 2023

Total Debt

—

Net Cash

$497,259

Enterprise Value

$124.2M

Debt / EBITDA

—

EV / EBITDA

—

Employees

—

Revenue

—

Adj. EBITDA

—

Net Income

$4.5M

FY 2024

EPS (Diluted)

—

Stock Price

$1.16

-11.5%

2026-03-06

52W Range

$1.14 – $35.20

P/E Ratio

—

Market Cap

$124.7M

Cash

$497,259

FY 2023

Total Debt

—

Net Cash

$497,259

Enterprise Value

$124.2M

Debt / EBITDA

—

EV / EBITDA

—

Employees

—